Media/Press
June 6, 2018 – BioSpace.com – Pfizer Adds $600 Million to Venture Arm with 25% Slated for Neuroscience
May 23, 2018 – Providence Business News – MindImmune Therapeutics agrees to acquire two programs from H. Lundbeck
May 23, 2018 – MedWatch – Lundbeck sells preclinical drugs to former research exec
May 22, 2018 – ConvergenceRI – The MindImmune research enterprise lifts off
May 22, 2018 – Lundbeck – Lundbeck divests preclinical research programs
Lundbeck divests preclinical research programs Two programs outside Lundbeck’s areas of focus are transferred to MindImmune Therapeutics, Inc. H. Lundbeck A/S (Lundbeck) further focuses its preclinical research pipeline with the divestment of two research programs...